Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors

被引:279
作者
Kathmann, M
Flau, K
Redmer, A
Tränkle, C
Schlicker, E
机构
[1] Univ Bonn, Sch Med, Dept Pharmacol & Toxicol, D-53113 Bonn, Germany
[2] Univ Bonn, Inst Pharm, Dept Pharmacol & Toxicol, D-53121 Bonn, Germany
关键词
H-3-DAMGO binding; H-3-naltrindole binding; (-)-Delta(9)-Tetrahydrocannabinol; cannabinoid CB1 receptor; rat cerebral cortex; rimonabant;
D O I
10.1007/s00210-006-0033-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanism of action of cannabidiol, one of the major constituents of cannabis, is not well understood but a noncompetitive interaction with mu opioid receptors has been suggested on the basis of saturation binding experiments. The aim of the present study was to examine whether cannabidiol is an allosteric modulator at this receptor, using kinetic binding studies, which are particularly sensitive for the measurement of allosteric interactions at G protein-coupled receptors. In addition, we studied whether such a mechanism also extends to the delta opioid receptor. For comparison, (-)-Delta(9)-tetrahydrocannabinol (THC; another major constituent of cannabis) and rimonabant ( a cannabinoid CB1 receptor antagonist) were studied. In mu opioid receptor binding studies on rat cerebral cortex membrane homogenates, the agonist H-3-DAMGO bound to a homogeneous class of binding sites with a K-D of 0.68 +/- 0.02 nM and a B-max of 203 +/- 7 fmol/mg protein. The dissociation of H-3-DAMGO induced by naloxone 10 mu M ( half life time of 7 +/- 1 min) was accelerated by cannabidiol and THC ( at 100 mu M, each) by a factor of 12 and 2, respectively. The respective pEC(50) values for a half-maximum elevation of the dissociation rate constant k(off) were 4.38 and 4.67; H-3-DAMGO dissociation was not affected by rimonabant 10 mu M. In delta opioid receptor binding studies on rat cerebral cortex membrane homogenates, the antagonist H-3-naltrindole bound to a homogeneous class of binding sites with a K-D of 0.24 +/- 0.02 nM and a B-max of 352 +/- 22 fmol/mg protein. The dissociation of H-3-naltrindole induced by naltrindole 10 mu M ( half life time of 119 +/- 3 min) was accelerated by cannabidiol and THC ( at 100 mu M, each) by a factor of 2, each. The respective pEC(50) values were 4.10 and 5.00; H-3-naltrindole dissociation was not affected by rimonabant 10 mu M. The present study shows that cannabidiol is an allosteric modulator at mu and delta opioid receptors. This property is shared by THC but not by rimonabant.
引用
收藏
页码:354 / 361
页数:8
相关论文
共 29 条
[1]   CHARACTERIZATION OF [H-3][ 2-D-PENICILLAMINE, 5-D-PENICILLAMINE] ENKEPHALIN BINDING TO DELTA-OPIATE RECEPTORS IN THE RAT-BRAIN AND NEUROBLASTOMA-GLIOMA HYBRID CELL-LINE (NG-108-15) [J].
AKIYAMA, K ;
GEE, KW ;
MOSBERG, HI ;
HRUBY, VJ ;
YAMAMURA, HI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2543-2547
[2]   The effects of cannabinoids on the brain [J].
Ameri, A .
PROGRESS IN NEUROBIOLOGY, 1999, 58 (04) :315-348
[3]   Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide [J].
Bisogno, T ;
Hanus, L ;
De Petrocellis, L ;
Tchilibon, S ;
Ponde, DE ;
Brandi, I ;
Moriello, AS ;
Davis, JB ;
Mechoulam, R ;
Di Marzo, V .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :845-852
[4]   EFFECT OF CANNABIDIOL ON CYTOCHROME-P-450 ISOZYMES [J].
BORNHEIM, LM ;
CORREIA, MA .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (17) :2789-2794
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[7]   ANTI-EPILEPTIC POTENTIAL OF CANNABIDIOL ANALOGS [J].
CONSROE, P ;
MARTIN, A ;
SINGH, V .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S428-S436
[8]   [H-3] NALTRINDOLE - A POTENT AND SELECTIVE LIGAND FOR LABELING DELTA-OPIOID RECEPTORS [J].
CONTRERAS, PC ;
TAM, L ;
DROWER, E ;
RAFFERTY, MF .
BRAIN RESEARCH, 1993, 604 (1-2) :160-164
[9]  
Dhawan BN, 1996, PHARMACOL REV, V48, P567
[10]   ANXIOLYTIC EFFECT OF CANNABIDIOL DERIVATIVES IN THE ELEVATED PLUS-MAZE [J].
GUIMARAES, FS ;
DEAGUIAR, JC ;
MECHOULAM, R ;
BREUER, A .
GENERAL PHARMACOLOGY, 1994, 25 (01) :161-164